These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15533490)

  • 41. Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.
    Hwang WL; Tendulkar RD; Niemierko A; Agrawal S; Stephans KL; Spratt DE; Hearn JW; Koontz BF; Lee WR; Michalski JM; Pisansky TM; Liauw SL; Abramowitz MC; Pollack A; Moghanaki D; Anscher MS; Den RB; Zietman AL; Stephenson AJ; Efstathiou JA
    JAMA Oncol; 2018 May; 4(5):e175230. PubMed ID: 29372236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial?
    Taguchi S; Shiraishi K; Fukuhara H; Nakagawa K; Morikawa T; Naito A; Kakutani S; Takeshima Y; Miyazaki H; Nakagawa T; Fujimura T; Kume H; Homma Y
    Radiat Oncol; 2016 Jul; 11():102. PubMed ID: 27475986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Radiotherapy for high-risk patients after radical prostatectomy for prostate cancer: immediate postoperative or salvage?].
    Pasquier D; Kouto H; Ballereau C
    Prog Urol; 2009 Jul; 19(7):447-56. PubMed ID: 19559374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA.
    Jang JW; Hwang WT; Guzzo TJ; Wein AJ; Haas NB; Both S; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1493-9. PubMed ID: 22401922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Adjuvant radiotherapy after radical prostatectomy as preventive treatment for biochemical recurrence].
    Olombrada MV; González AA; Villoslada CI; Perea BC; Martinez BL; Guerra PC
    Arch Esp Urol; 2012; 65(1):122-30. PubMed ID: 22322647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?
    King CR; Presti JC; Gill H; Brooks J; Hancock SL
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):341-7. PubMed ID: 15145146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant and salvage radiotherapy after prostatectomy: outcome analysis of 307 patients with prostate cancer.
    Detti B; Scoccianti S; Cassani S; Cipressi S; Villari D; Lapini A; Saieva C; Cai T; Pertici M; Giacomelli I; Livi L; Ceroti M; Nicita G; Carini M; Biti G
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):147-57. PubMed ID: 22986810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early PSA level decline is an independent predictor of biochemical and clinical control for salvage postprostatectomy radiotherapy.
    Blanchard P; Bakkour M; De Crevoisier R; Levy A; Baumert H; Patard JJ; Wibault P; Fizazi K; Bossi A
    Urol Oncol; 2015 Mar; 33(3):108.e15-20. PubMed ID: 25176583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy: A propensity score-matched analysis.
    Song C; Kang HC; Kim JS; Eom KY; Kim IA; Chung JB; Hong SK; Byun SS; Lee SE
    Strahlenther Onkol; 2015 Oct; 191(10):801-9. PubMed ID: 26159555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
    Wiegel T; Lohm G; Bottke D; Höcht S; Miller K; Siegmann A; Schostak M; Neumann K; Hinkelbein W
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1009-16. PubMed ID: 18963539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Salvage radiotherapy in rising PSA after radical prostatectomy].
    Carrie C; Pommier P
    Cancer Radiother; 2007 Nov; 11(6-7):370-2. PubMed ID: 17869564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk stratification of patients with extraprostatic extension and negative lymph nodes at radical prostatectomy: identifying optimal candidates for adjuvant therapy.
    Eisenberg MS; Karnes RJ; Kaushik D; Rangel L; Bergstralh EJ; Boorjian SA
    J Urol; 2013 Nov; 190(5):1735-41. PubMed ID: 23727312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients.
    Cozzarini C; Montorsi F; Fiorino C; Alongi F; Bolognesi A; Da Pozzo LF; Guazzoni G; Freschi M; Roscigno M; Scattoni V; Rigatti P; Di Muzio N
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):966-74. PubMed ID: 19619960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy.
    Eggener SE; Roehl KA; Smith ND; Antenor JA; Han M; Catalona WJ
    J Urol; 2005 Apr; 173(4):1150-5. PubMed ID: 15758725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy.
    Tsien C; Griffith KA; Sandler HM; McLaughlin P; Sanda MG; Montie J; Reddy S; Hayman JA
    Urology; 2003 Jul; 62(1):93-8. PubMed ID: 12837430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy.
    Kupelian PA; Elshaikh M; Reddy CA; Zippe C; Klein EA
    J Clin Oncol; 2002 Aug; 20(16):3376-85. PubMed ID: 12177097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy.
    Macdonald OK; Schild SE; Vora SA; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1530-5. PubMed ID: 15050333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conformal postoperative radiotherapy in patients with positive resection margins and/or pT3-4 prostate adenocarcinoma.
    Bellavita R; Massetti M; Abraha I; Lupattelli M; Mearini L; Falcinelli L; Farneti A; Palumbo I; Porena M; Aristei C
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e299-304. PubMed ID: 22572075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery.
    Chang JH; Park W; Park JS; Pyo H; Huh SJ; Choi HY; Lee HM; Jeon SS; Seo SI
    Int J Urol; 2015 Jan; 22(1):82-7. PubMed ID: 25208624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
    Bianco FJ; Scardino PT; Stephenson AJ; Diblasio CJ; Fearn PA; Eastham JA
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):448-53. PubMed ID: 15890586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.